NUCKS overexpression in breast cancer

被引:34
作者
Drosos, Yiannis [2 ]
Kouloukoussa, Mirsini [1 ]
Ostvold, Anne Carine [3 ]
Grundt, Kirsten [3 ]
Goutas, Nikos [4 ]
Vlachodimitropoulos, Dimitrios [4 ]
Havaki, Sophia [1 ]
Kollia, Panagoula [2 ]
Kittas, Christos [1 ]
Marinos, Evangelos [1 ]
Aleporou-Marinou, Vassiliki [2 ]
机构
[1] Univ Athens, Sch Med, Lab Histol & Embryol, Goudi 11527, Greece
[2] Univ Athens, Fac Biol, Dept Genet & Biotechnol, Panepistimioupoli 15701, Ilissia, Greece
[3] Univ Oslo, Inst Basic Med Sci, Dept Biochem, N-0317 Oslo, Norway
[4] Univ Athens, Sch Med, Lab Forens Med & Toxicol, Goudi 11527, Greece
来源
CANCER CELL INTERNATIONAL | 2009年 / 9卷
关键词
COMPARATIVE GENOMIC HYBRIDIZATION; GROUP-LIKE PROTEIN; CARCINOMA IN-SITU; GENETIC ALTERATIONS; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; P1; RECOMBINATION; ABERRATIONS;
D O I
10.1186/1475-2867-9-19
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: NUCKS (Nuclear, Casein Kinase and Cyclin-dependent Kinase Substrate) is a nuclear, DNA-binding and highly phosphorylated protein. A number of reports show that NUCKS is highly expressed on the level of mRNA in several human cancers, including breast cancer. In this work, NUCKS expression on both RNA and protein levels was studied in breast tissue biopsies consisted of invasive carcinomas, intraductal proliferative lesions, benign epithelial proliferations and fibroadenomas, as well as in primary cultures derived from the above biopsies. Specifically, in order to evaluate the level of NUCKS protein in correlation with the histopathological features of breast disease, immunohistochemistry was employed on paraffin sections of breast biopsies of the above types. In addition, NUCKS expression was studied by means of Reverse Transcription PCR (RT-PCR), real-time PCR (qRT-PCR) and Western immunoblot analyses in the primary cell cultures developed from the same biopsies. Results: The immunohistochemical Results showed intense NUCKS staining mostly in grade I and II breast carcinomas compared to normal tissues. Furthermore, NUCKS was moderate expressed in benign epithelial proliferations, such as adenosis and sclerosing adenosis, and highly expressed in intraductal lesions, specifically in ductal carcinomas in situ (DCIS). It is worth noting that all the fibroadenoma tissues examined were negative for NUCKS staining. RT-PCR and qRT-PCR showed an increase of NUCKS expression in cells derived from primary cultures of proliferative lesions and cancerous tissues compared to the ones derived from normal breast tissues and fibroadenomas. This increase was also confirmed by Western immunoblot analysis. Although NUCKS is a cell cycle related protein, its expression does not correlate with Ki67 expression, neither in tissue sections nor in primary cell cultures. Conclusion: The results show overexpression of the NUCKS protein in a number of non malignant breast lesions and cancerous tissues. In particular, the NUCKS overexpression in ADH and DCIS indicates a significant role of this protein in neoplastic progression.
引用
收藏
页数:14
相关论文
共 37 条
  • [21] Genetic determinants of cancer metastasis
    Nguyen, Don X.
    Massague, Joan
    [J]. NATURE REVIEWS GENETICS, 2007, 8 (05) : 341 - 352
  • [22] Nishizaki T, 1997, INT J CANCER, V74, P513, DOI 10.1002/(SICI)1097-0215(19971021)74:5<513::AID-IJC6>3.3.CO
  • [23] 2-X
  • [24] Array-based comparative genomic hybridization of ductal carcinoma in situ and synchronous invasive lobular cancer
    Nyante, SJ
    Devries, S
    Chen, YY
    Hwang, ES
    [J]. HUMAN PATHOLOGY, 2004, 35 (06) : 759 - 763
  • [25] Molecular cloning of a mammalian nuclear phosphoprotein NUCKS, which serves as a substrate for Cdk1 in vivo
    Ostvold, AC
    Norum, JH
    Mathiesen, S
    Wanvik, B
    Sefland, I
    Grundt, K
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (08): : 2430 - 2440
  • [26] Current status of prognostic profiling in breast cancer
    Pusztai, Lajos
    [J]. ONCOLOGIST, 2008, 13 (04) : 350 - 360
  • [27] HISTOLOGICAL GRADING OF BREAST CARCINOMAS - A STUDY OF INTEROBSERVER AGREEMENT
    ROBBINS, P
    PINDER, S
    DEKLERK, N
    DAWKINS, H
    HARVEY, J
    STERRETT, G
    ELLIS, I
    ELSTON, C
    [J]. HUMAN PATHOLOGY, 1995, 26 (08) : 873 - 879
  • [28] Chromosomal changes in high- and low-invasive mouse lung adenocarcinoma cell strains derived from early passage mouse lung adenocarcinoma cell strains
    Sargent, Linda M.
    Ensell, Mang X.
    Ostvold, Anne-Caring
    Baldwin, Kimberly T.
    Kashon, Michael L.
    Lowry, David T.
    Senft, Jamie R.
    Jefferson, Amy M.
    Johnson, Robert C.
    Li, Zhi
    Tyson, Frederick L.
    Reynolds, Steven H.
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2008, 233 (01) : 81 - 91
  • [29] Gene expression patterns in ovarian carcinomas
    Schaner, ME
    Ross, DT
    Ciaravino, G
    Sorlie, T
    Troyanskaya, O
    Diehn, M
    Wang, YC
    Duran, GE
    Sikic, TL
    Caldeira, S
    Skomedal, H
    Tu, IP
    Hernandez-Boussard, T
    Johnson, SW
    O'Dwyer, PJ
    Fero, MJ
    Kristensen, GB
    Borresen-Dale, AL
    Hastie, T
    Tibshirani, R
    van de Rijn, M
    Teng, NN
    Longacre, TA
    Botstein, D
    Brown, PO
    Sikic, BI
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2003, 14 (11) : 4376 - 4386
  • [30] Molecular evolution of breast cancer
    Simpson, PT
    Reis-Filho, JS
    Gale, T
    Lakhani, SR
    [J]. JOURNAL OF PATHOLOGY, 2005, 205 (02) : 248 - 254